Tenzing and Reviva Pharmaceuticals announced in a filing that Narayan Prabhu has been recruited to join the combined public company as CFO, following completion of the merger. A shareholder vote is set for Dec. 8 on the proposed merger with Reviva, a California-based clinical stage pharmaceutical company. If approved, the combined companies would have a valuation of $119M. Read more.
Tenzing and Reviva Announce New CFO
